BROOKE MARTIN: Open Payments
NPI 1588251383 · WEBSTER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$427 in 9 payments from 4 companies in 2025. Trend: 2023 $709 · 2024 $327 · 2025 $427
Food & beverage: $427
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 2 | $158 |
| Amgen Inc. | 3 | $135 |
| GlaxoSmithKline, LLC. | 2 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
Products named: ULTOMIRIS, EVENITY, NUCALA, VPRIV.
Industry payments across TX — which companies pay providers there.
